Back to mobile site

BMO Capital Pounding Table on Eli Lilly (LLY): 'We'd Be Buyers'

December 11, 2023 1:40 PM EST Send to a Friend
BMO Capital analyst Evan David Seigerman reiterated an Outperform rating and $710.00 price target on Eli Lilly (NYSE: LLY)The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login